{
    "Trade/Device Name(s)": [
        "Audit\u2122M MicroCVTM Homocysteine Linearity Set",
        "Homocysteine Linearity Set"
    ],
    "Submitter Information": "Aalto Scientific, Ltd.",
    "510(k) Number": "K100715",
    "Predicate Device Reference 510(k) Number(s)": [
        "K984071",
        "K042318"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "JJX"
    ],
    "Summary Letter Date": "December 23, 2010",
    "Summary Letter Received Date": "November 23, 2010",
    "Submission Date": "November 22, 2010",
    "Regulation Number(s)": [
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Quality control material (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology"
    ],
    "Analyte(s)": [
        "Homocysteine"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Quality control material",
        "Linearity set"
    ],
    "Document Summary": "FDA 510(k) summary for Audit\u2122M MicroCVTM Homocysteine Linearity Set, a five-level human serum-based quality control material for verifying linearity and reportable range of homocysteine assays.",
    "Indications for Use Summary": "Assayed human serum-based quality control with five levels of homocysteine to verify linearity, calibration verification, and reportable range in quantitative homocysteine assays; not for assay calibration or standardization.",
    "fda_folder": "Clinical Chemistry"
}